Novembre 2019

INDEX

JOURNAL CLUB (page 4)
Five-Year Survival in 60% in Advanced Melanoma
Lichen Planus: Progress Towards a Specific Therapy
A New Biologic Targetting The Alarmin Cytokine IL33 May Win The Race For Atopic Dermatitis Control
How Much Testosterone For Inducing Acne. The Trans Gender Model
Next Generation Anti-IgE Treatment For Urticaria
Mechanisms of Itch in Stasis Dermatitis
Transcriptomics Of Skin TreatedwithTopicalClobetasol Similar To Aged Skin

FOCUS (page 10)
Stem Cell Secretome: A New Booster or An Expensive Soup In Aging ?
Prevalence of Dermatoporosis Highest in Pemphigoid!! Guess Why!
Hematomas of Dermatoporosis Have More Morbidity Than Hip Fractures!
Nicotinamide An Anti Aging Molecule
Metabolic Reprograming Is Emerging As a Key Target In Skin Anti Aging
The Four Emerging Rejuvenation Strategies
A Breakthrough!!! Senolytic Drugs Decrease Senescent Cell In Humans

SGDV / SSDV (page 16)
PROTOKOLL der 101. Generalversammlung der SGDV
PROCÈS-VERBAL de la 101e Assemblée Générale de la SSDV

Reports (page 30)
Eine neue Form des Schleimhautpemphigoids: Orales Schleimhautpemphigoid vom Lichen Typ

Terminologie (page 33)
Clavus, Hühnerauge / Cor, œil de perdrix

Photo of the month (page 35)

Industrie (page 38)
Ilumetri® (Tildrakizumab) überzeugt durch nachhaltige Wirkung und schlanke Anwendungsintervalle